The Music Settlement, Cleveland, OH, USA.
J Speech Lang Hear Res. 2012 Oct;55(5):1463-71. doi: 10.1044/1092-4388(2012/11-0105). Epub 2012 Mar 12.
Positive results have been reported with melodic intonation therapy (MIT) in nonfluent aphasia patients with damage to their left-brain speech processes, using the patient's intact ability to sing to promote functional language. This pilot study sought to determine the immediate effects of introducing modified melodic intonation therapy (MMIT), a modification of MIT, as an early intervention in stroke patients presenting with Broca's aphasia.
After a randomized controlled single-blind design, 30 acute stroke survivors with nonfluent aphasia were randomly assigned to receive MIT treatment or no treatment. A pre/post test, based on the responsive and repetition subsections of the Western Aphasia Battery, was developed for this study.
After 1 session, a significant within-subject change was observed for the treatment group's adjusted total score ( p = .02), and a significant difference between groups was found for adjusted total score ( p = .02) favoring the treatment group. The treatment group also showed a significant change in their responsive subsection scores ( p = .01) when their pre-tests from Visit 1 to Visit 2 were compared, whereas the control group showed no change, suggesting a possible carry-over effect of MIT treatment.
This study provides preliminary data supporting the possible benefits of utilizing MMIT treatment early in the recovery of nonfluent aphasia patients.
旋律语调疗法(MIT)已被报道在左脑言语损伤的非流利型失语症患者中取得了积极的效果,该疗法利用患者未受损的歌唱能力来促进功能性语言。本研究旨在探究作为早期干预手段,将改良旋律语调疗法(MMIT)引入到以布罗卡失语症为表现的急性脑卒中患者中的即刻效果。
采用随机对照单盲设计,将 30 名急性脑卒中后非流利型失语症患者随机分为接受 MIT 治疗组和未治疗组。本研究设计了基于西方失语症成套测验的反应性和复述两个分量表的预/后测试。
治疗组在接受 1 次治疗后,其校正总分在组内具有显著变化(p =.02),且治疗组与对照组间校正总分存在显著差异(p =.02),治疗组更具优势。与第 1 次就诊时的预测试相比,治疗组在反应性分量表的得分上具有显著变化(p =.01),而对照组则没有变化,这表明 MIT 治疗可能具有延续效果。
本研究提供了初步数据,支持在非流利型失语症患者康复的早期阶段应用 MMIT 治疗的可能益处。